Search - tctmd.com

Displaying 781 - 800 of 2327

Sort: Relevancy | Date

Presentation TVT 2022

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

Presenter: Marc Allard-Ratick

June 08, 2022

Presentation TVT 2022

One-year outcomes of the Cardioband TR early feasibility study for functional tricuspid regurgitation

Presenter: William Gray

June 08, 2022

Presentation TVT 2022

A Transseptal Approach to the Treatment of Mitral Regurgitation

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Alternative Transcatheter Solutions

Presenter: Lauren Ranard

June 08, 2022

Presentation TVT 2022

Frequency, Mechanisms, and Current Management

Presenter: Nir Uriel

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

Presenter: Vinod Thourani

June 08, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

News Daily News

Medtronic Recalls Harmony Delivery Catheters Due to Breakage Risk

L.A. McKeown

April 26, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

Advertisement

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

One-year outcomes of the Cardioband TR early feasibility study for functional tricuspid regurgitation

A Transseptal Approach to the Treatment of Mitral Regurgitation

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Alternative Transcatheter Solutions

Frequency, Mechanisms, and Current Management

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

TCTMD’s Top 10 Most Popular Stories for May 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Medtronic Recalls Harmony Delivery Catheters Due to Breakage Risk

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content